JP2002501077A - Ｍｅｔｈ１およびｍｅｔｈ２のポリヌクレオチドおよびポリペプチド - Google Patents

Ｍｅｔｈ１およびｍｅｔｈ２のポリヌクレオチドおよびポリペプチド

Info

Publication number
JP2002501077A
JP2002501077A JP2000528581A JP2000528581A JP2002501077A JP 2002501077 A JP2002501077 A JP 2002501077A JP 2000528581 A JP2000528581 A JP 2000528581A JP 2000528581 A JP2000528581 A JP 2000528581A JP 2002501077 A JP2002501077 A JP 2002501077A
Authority
JP
Japan
Prior art keywords
seq
polypeptide
meth1
amino acids
meth2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000528581A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002501077A5 (enExample
Inventor
ルイザ イルエラ−アリスペ，
グレッグ エイ． ヘイスティングス，
スティーブン エム． ルーベン，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beth lsrael Deaconess Medical Center
Human Genome Sciences Inc
Original Assignee
Beth lsrael Deaconess Medical Center
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beth lsrael Deaconess Medical Center, Human Genome Sciences Inc filed Critical Beth lsrael Deaconess Medical Center
Publication of JP2002501077A publication Critical patent/JP2002501077A/ja
Publication of JP2002501077A5 publication Critical patent/JP2002501077A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2000528581A 1998-01-23 1999-01-22 Ｍｅｔｈ１およびｍｅｔｈ２のポリヌクレオチドおよびポリペプチド Pending JP2002501077A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US7229898P 1998-01-23 1998-01-23
US9853998P 1998-08-28 1998-08-28
US60/072,298 1998-08-28
US60/098,539 1998-08-28
PCT/US1999/001313 WO1999037660A1 (en) 1998-01-23 1999-01-22 Meth1 and meth2 polynucleotides and polypeptides

Publications (2)

Publication Number Publication Date
JP2002501077A true JP2002501077A (ja) 2002-01-15
JP2002501077A5 JP2002501077A5 (enExample) 2006-02-23

Family

ID=26753215

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000528581A Pending JP2002501077A (ja) 1998-01-23 1999-01-22 Ｍｅｔｈ１およびｍｅｔｈ２のポリヌクレオチドおよびポリペプチド

Country Status (9)

Country Link
EP (1) EP1049708A4 (enExample)
JP (1) JP2002501077A (enExample)
KR (1) KR20010086224A (enExample)
CN (1) CN1292796A (enExample)
AU (1) AU766787B2 (enExample)
CA (1) CA2319109A1 (enExample)
MX (1) MXPA00007165A (enExample)
NZ (1) NZ505855A (enExample)
WO (1) WO1999037660A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6416974B1 (en) 1997-08-06 2002-07-09 Millennium Pharmaceuticals, Inc. Tango 71 nucleic acids
DE19806581A1 (de) * 1998-02-17 1999-10-21 Forschungszentrum Juelich Gmbh Sequenzen eines Ih-Ionenkanals und deren Verwendung
US6649377B1 (en) * 1999-05-10 2003-11-18 Syntex (U.S.A.) Llc Human aggrecanase and nucleic acid compositions encoding the same
ATE444971T1 (de) * 1999-06-09 2009-10-15 Genentech Inc Zusammensetzungen und verfahren für die tumor- behandlung
US6395889B1 (en) * 1999-09-09 2002-05-28 Millennium Pharmaceuticals, Inc. Nucleic acid molecules encoding human protease homologs
EP1892250A3 (en) * 2000-01-31 2008-09-17 Munin Corporation CYR61 compositions and methods
WO2001074852A2 (en) * 2000-03-31 2001-10-11 Bayer Corporation Protein having activity as an angiogenesis modulator
JP2002330761A (ja) * 2000-04-26 2002-11-19 Pfizer Prod Inc Ａｄａｍｔｓポリペプチド、それをコードする核酸、及びその使用
JP2004524003A (ja) * 2000-06-29 2004-08-12 コリクサ コーポレイション 肺癌の治療および診断のための組成物および方法
IL158293A0 (en) 2001-04-10 2004-05-12 Agensys Inc Nucleic acid and corresponding protein entitled 158p3d2 and pharmaceutical compositions containing the same
AU2002364161A1 (en) 2001-12-12 2003-06-23 Aventis Pasteur Limited Enhancement of the immune response using cd36-binding domain
ATE441713T1 (de) 2002-09-27 2009-09-15 Dainippon Sumitomo Pharma Co Tumorantigenprotein und dessen verwendung
JP5606322B2 (ja) 2008-10-20 2014-10-15 昇志 佐藤 腫瘍抗原ペプチド及びその利用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6565858B2 (en) * 1997-06-03 2003-05-20 Kureha Chemical Industry Co., Ltd. Human ADAMTS-1 protein and pharmaceutical composition
US6416974B1 (en) * 1997-08-06 2002-07-09 Millennium Pharmaceuticals, Inc. Tango 71 nucleic acids

Also Published As

Publication number Publication date
KR20010086224A (ko) 2001-09-10
CA2319109A1 (en) 1999-07-29
EP1049708A4 (en) 2002-09-04
AU2464199A (en) 1999-08-09
CN1292796A (zh) 2001-04-25
WO1999037660A1 (en) 1999-07-29
WO1999037660A9 (en) 1999-10-14
AU766787B2 (en) 2003-10-23
MXPA00007165A (es) 2002-06-21
NZ505855A (en) 2005-01-28
EP1049708A1 (en) 2000-11-08

Similar Documents

Publication Publication Date Title
JP2002516103A (ja) インターロイキン２１およびインターロイキン２２
US20090088555A1 (en) 44 Human Secreted Proteins
JP2002521055A (ja) ９８個のヒト分泌タンパク質
US20030204071A1 (en) 109 human secreted proteins
US20070248593A1 (en) 32 Human Secreted Proteins
US7906634B2 (en) HEMCM42 nucleic acids
JP2009131263A (ja) ５０個のヒト分泌タンパク質
JP2002533058A (ja) ９７個のヒト分泌タンパク質
JP2001520039A (ja) ヒト腫瘍壊死因子レセプター様タンパク質、ｔｒ１１，ｔｒ１１ｓｖ１およびｔｒ１１ｓｖ２
JP2005218453A (ja) ８７個のヒト分泌タンパク質
EP1093457B1 (en) Cytokine receptor common gamma chain like
JP2002501738A (ja) ６７個のヒト分泌タンパク質
JP2002500035A (ja) ３６個のヒト分泌タンパク質
JP2001514885A (ja) ７０個のヒト分泌タンパク質
JP2002520050A (ja) ７１個のヒト分泌タンパク質
US7053190B2 (en) Secreted protein HRGDF73
US6844170B1 (en) Cytokine receptor common gamma chain like
JP2003524366A (ja) ６４個のヒト分泌タンパク質
JP2002505871A (ja) ３１個のヒト分泌タンパク質
JP2002514925A (ja) １９個のヒト分泌タンパク質
WO2000006589A9 (en) Prostate derived ets factor
AU2464199A (en) Meth1 and meth2 polynucleotides and polypeptides
JP2001519179A (ja) ５３個のヒト分泌タンパク質
JP2003521865A (ja) １４８個のヒト分泌タンパク質
JP2003521216A (ja) ９０個のヒト分泌タンパク質

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051227

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051227

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080912

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090223